SHSE:688278 (China)
Â
Class A
Â¥
60.63
+1.73 (+2.94%)
Jul 27
Business Description
Xiamen Amoytop Biotech Co Ltd
ISIN : CNE100003RT3
Share Class Description:
SHSE:688278: Class ATotal Employee Number:
3,644Compare
Compare
Traded in other countries / regions
688278.China Index Membership
SSE Composite IndexCSI 500 Index IPO Date
2020-01-17Description
Xiamen Amoytop Biotech Co Ltd operates as a drug development company. The Company develops and sells protein drugs, interferon drugs, and other products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 5.82 | |||||
Equity-to-Asset | 0.81 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | 0.16 | |||||
Interest Coverage | 611.79 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 20.39 | |||||
Beneish M-Score | -1.79 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 33.7 | |||||
3-Year EBITDA Growth Rate | 47 | |||||
3-Year EPS without NRI Growth Rate | 46.7 | |||||
3-Year FCF Growth Rate | 48.1 | |||||
3-Year Book Growth Rate | 34.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 26.33 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 22.24 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.12 | |||||
9-Day RSI | 55.62 | |||||
14-Day RSI | 54.86 | |||||
3-1 Month Momentum % | -6.41 | |||||
6-1 Month Momentum % | -27.85 | |||||
12-1 Month Momentum % | -28.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.79 | |||||
Quick Ratio | 4.05 | |||||
Cash Ratio | 1.87 | |||||
Days Inventory | 447.31 | |||||
Days Sales Outstanding | 78.21 | |||||
Days Payable | 107.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.03 | |||||
Dividend Payout Ratio | 0.25 | |||||
3-Year Dividend Growth Rate | 83.7 | |||||
Forward Dividend Yield % | 1.03 | |||||
5-Year Yield-on-Cost % | 28.01 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 0.54 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 92.2 | |||||
Operating Margin % | 31.92 | |||||
Net Margin % | 26.53 | |||||
EBITDA Margin % | 30.03 | |||||
FCF Margin % | 10.1 | |||||
OCF Margin % | 17.2 | |||||
ROE % | 32.5 | |||||
ROA % | 26.66 | |||||
ROIC % | 42.87 | |||||
3-Year ROIIC % | 41.59 | |||||
ROC (Joel Greenblatt) % | 69.73 | |||||
ROCE % | 34.9 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 24.55 | |||||
Forward PE Ratio | 19 | |||||
PE Ratio without NRI | 24.62 | |||||
Shiller PE Ratio | 77.73 | |||||
Price-to-Owner-Earnings | 30.43 | |||||
PEG Ratio | 0.48 | |||||
PS Ratio | 6.52 | |||||
PB Ratio | 6.82 | |||||
Price-to-Tangible-Book | 7.74 | |||||
Price-to-Free-Cash-Flow | 64.9 | |||||
Price-to-Operating-Cash-Flow | 38.04 | |||||
EV-to-EBIT | 20.79 | |||||
EV-to-EBITDA | 20.79 | |||||
EV-to-Revenue | 6.24 | |||||
EV-to-FCF | 61.83 | |||||
Price-to-GF-Value | 0.57 | |||||
Price-to-Projected-FCF | 4.52 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.98 | |||||
Price-to-Graham-Number | 2.91 | |||||
| Price-to-Net-Current-Asset-Value | 12.68 | |||||
| Price-to-Net-Cash | 97.79 | |||||
Earnings Yield (Greenblatt) % | 4.81 | |||||
FCF Yield % | 1.56 | |||||
Forward Rate of Return (Yacktman) % | 20.89 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Xiamen Amoytop Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 3,820.014 | ||
| EPS (TTM) (Â¥) | 2.47 | ||
| Beta | 0.6651 | ||
| 3-Year Sharpe Ratio | 0.25 | ||
| 3-Year Sortino Ratio | 0.43 | ||
| Volatility % | 39.46 | ||
| 14-Day RSI | 54.86 | ||
| 14-Day ATR (Â¥) | 2.665616 | ||
| 20-Day SMA (Â¥) | 57.4255 | ||
| 12-1 Month Momentum % | -28.17 | ||
| 52-Week Range (Â¥) | 50 - 93.52 | ||
| Shares Outstanding (Mil) | 408.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Xiamen Amoytop Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Xiamen Amoytop Biotech Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| CNY 0.620000 Cash Dividend | 2026-05-29 | 55.69 (+0.89%) | ||
| CNY 0.620000 Cash Dividend | 2025-05-09 | 74.24 (+0.72%) |
Show
Entries
Xiamen Amoytop Biotech Co Ltd Frequently Asked Questions
What is Xiamen Amoytop Biotech Co Ltd(SHSE:688278)'s stock price today?
The current price of SHSE:688278 is ¥60.63. The 52 week high of SHSE:688278 is ¥93.52 and 52 week low is ¥50.00.
When is next earnings date of Xiamen Amoytop Biotech Co Ltd(SHSE:688278)?
The next earnings date of Xiamen Amoytop Biotech Co Ltd(SHSE:688278) is .
Does Xiamen Amoytop Biotech Co Ltd(SHSE:688278) pay dividends? If so, how much?
The Dividend Yield %  of Xiamen Amoytop Biotech Co Ltd(SHSE:688278) is 1.03% (As of Today), Highest Dividend Payout Ratio of Xiamen Amoytop Biotech Co Ltd(SHSE:688278) was 0.25. The lowest was 0.09. And the median was 0.14. The  Forward Dividend Yield % of Xiamen Amoytop Biotech Co Ltd(SHSE:688278) is 1.03%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Xiamen Amoytop Biotech Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers